Literature DB >> 33826420

An Evaluation of Two Capillary Sample Collection Kits for Laboratory Measurement of HbA1c.

Roy W Beck1, Laura E Bocchino1, John W Lum1, Craig Kollman1, Victoria Barnes-Lomen1, Mark Sulik2, Michael J Haller3, Bruce Bode4, Joseph T Cernich5, Anthony A Killeen6, Uttam Garg7, David Liljenquist2, Janey G Adams3, Margaret Clements4, Deanna Gabrielson6, Terri Johnson7, Mark A Clements5.   

Abstract

Background: The COVID-19 pandemic has impacted the conduct of clinic visits. We conducted a study to evaluate two academic laboratories' fingerstick capillary blood collection kits suitable for home use for laboratory measurement of HbA1c.
Methods: Four clinical sites recruited 240 participants (aged 4-80 years, HbA1c 5.1%-13.5%). Capillary blood samples were obtained by the participant or parent using collection kits from two laboratories (University of Minnesota Advanced Research and Diagnostic Laboratory (ARDL) and Children's Mercy Hospital Laboratory (CMH)) and mailed under varying shipping conditions by United States Postal Service to the laboratories. Comparisons were made between HbA1c measurements from capillary samples and contemporaneously obtained venous samples. The primary outcome was percentage of capillary HbA1c values within 5% of the corresponding venous values.
Results: HbA1c values were within 5% of venous values for 96% of ARDL kit specimens shipped with a cold pack and 98% without a cold pack and 99% and 99%, respectively, for the CMH kits. R2 values were 0.98, 0.99, 0.99, and 0.99, respectively. Results appeared similar across HbA1c levels and for pediatric and adult participants. Usability survey scores were high. Conclusions: Capillary blood collection kits, suitable for home use, from two academic laboratories, were demonstrated to be easy to use and provided results that are comparable with those obtained from venous specimens. Based on these results, there is strong evidence that HbA1c measurements from capillary specimens obtained with these specific kits can be used interchangeably with HbA1c measurements from venous specimens for clinical research and clinical care.

Entities:  

Keywords:  Accuracy; HbA1c measurement; Home A1c testing; Type 1 diabetes; Type 2 diabetes; adults; children

Year:  2021        PMID: 33826420     DOI: 10.1089/dia.2021.0023

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  7 in total

1.  Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Type 1 Diabetes: the Pilot 4T Study.

Authors:  Priya Prahalad; Victoria Y Ding; Dessi P Zaharieva; Ananta Addala; Ramesh Johari; David Scheinker; Manisha Desai; Korey Hood; David M Maahs
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

2.  The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes.

Authors:  Jane Lynch; Lauren G Kanapka; Steven J Russell; Edward R Damiano; Firas H El-Khatib; Katrina J Ruedy; Courtney Balliro; Peter Calhoun; Roy W Beck
Journal:  Diabetes Technol Ther       Date:  2022-10       Impact factor: 7.337

3.  A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes.

Authors:  Roy W Beck; Steven J Russell; Edward R Damiano; Firas H El-Khatib; Katrina J Ruedy; Courtney Balliro; Zoey Li; Peter Calhoun
Journal:  Diabetes Technol Ther       Date:  2022-10       Impact factor: 7.337

4.  Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.

Authors:  Laurel H Messer; Bruce A Buckingham; Fran Cogen; Mark Daniels; Greg Forlenza; Rabab Z Jafri; Nelly Mauras; Andrew Muir; R Paul Wadwa; Perrin C White; Steven J Russell; Edward R Damiano; Firas H El-Khatib; Katrina J Ruedy; Courtney A Balliro; Zoey Li; Martin Chase Marak; Peter Calhoun; Roy W Beck
Journal:  Diabetes Technol Ther       Date:  2022-10       Impact factor: 7.337

5.  Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies.

Authors:  David M Nathan; Heidi Krause-Steinrauf; Barbara H Braffett; Valerie L Arends; Naji Younes; Paula McGee; Claire Lund; Mary Johnson; Gayle Lorenzi; Xiaoyu Gao; Michael W Steffes; John M Lachin
Journal:  PLoS One       Date:  2021-11-15       Impact factor: 3.240

6.  Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.

Authors:  Thomas Martens; Roy W Beck; Ryan Bailey; Katrina J Ruedy; Peter Calhoun; Anne L Peters; Rodica Pop-Busui; Athena Philis-Tsimikas; Shichun Bao; Guillermo Umpierrez; Georgia Davis; Davida Kruger; Anuj Bhargava; Laura Young; Janet B McGill; Grazia Aleppo; Quang T Nguyen; Ian Orozco; William Biggs; K Jean Lucas; William H Polonsky; John B Buse; David Price; Richard M Bergenstal
Journal:  JAMA       Date:  2021-06-08       Impact factor: 56.272

7.  The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin.

Authors:  Grazia Aleppo; Roy W Beck; Ryan Bailey; Katrina J Ruedy; Peter Calhoun; Anne L Peters; Rodica Pop-Busui; Athena Philis-Tsimikas; Shichun Bao; Guillermo Umpierrez; Georgia Davis; Davida Kruger; Anuj Bhargava; Laura Young; John B Buse; Janet B McGill; Thomas Martens; Quang T Nguyen; Ian Orozco; William Biggs; K Jean Lucas; William H Polonsky; David Price; Richard M Bergenstal
Journal:  Diabetes Care       Date:  2021-09-29       Impact factor: 19.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.